The metabolic findings of Bradley et al. indicate that adipose-derived CLU inhibits the insulin signaling pathway and directly contributes to insulin resistance by enhancing gluconeogenesis, thereby substantiating the biological correlation of CLU with PCOS and metabolic syndrome in our study [20]. This evidence concerns the gene INS and polycystic ovary syndrome.